In the third episode of Respiratory Life, Brian Kent is joined by respiratory consultants Laura Gleeson, Imran Sulaiman and Breda Cushen.

The panel briefly discuss a recently published New England Journal of Medicine paper on the treatment strategy for rifampin-susceptible tuberculosis. This is followed by an in-depth discussion of artificial intelligence: what it is, how its use can be applied to healthcare, and potential opportunities and challenges.

Read the New England Journal of Medicine paper in full here.

Listen on Soundcloud

Listen on Spotify